NEWS and OPINIONS
Why Does This Hybrid Monkey Glow Green?
By Meghan Bartels - Scientific American Scientists have just achieved a milestone in stem-cell biology after creating a monkey from two embryos. And proof of the achievement, perhaps unnervingly, showed up in the infant primate’s eerie green glow. Although research...
Stem cell research paves way toward regenerating skeletal muscle
by Sarah C.P. Williams, UCLA - Phys.org News Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA are one step closer to developing stem cell therapies to regenerate skeletal muscle in humans. Working in mice, the...
Sharing the Serendipity of Science: How Cell Developmental Biology Fits Into the Future of Medicine
by Tristan Epps - Penn Medicine News Ben Stanger, MD, PhD is a practicing Gastroenterologist at Penn Medicine. He is also the Hanna Wise Professor in Cancer Research and professor of Medicine and Cell and Developmental biology at the University of Pennsylvania....
‘Super Melanin’ Heals Skin Injuries From Sunburn, Chemical Burns
By Marla Paul - Northwestern Medicine Synthetic cream also protects skin from sun damage Imagine a skin cream that heals damage occurring throughout the day when your skin is exposed to sunlight or environmental toxins. That’s the potential of a synthetic, biomimetic...
Researchers identify new criteria to detect rapidly progressive dementia
Mayo Clinic researchers have identified new scoring criteria allowing for the detection of treatable forms of rapidly progressive dementia (RPD) with reasonably high confidence during a patient's first clinical visit. This scoring criteria may allow physicians to...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/U5VZBBJ5SBJARD5TTCJHHDF6VM.jpg "FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study")
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
By Reuters News Oct 31 (Reuters) - A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals (VRTX.O) and CRISPR Therapeutics (CRSP.BN) could assess potential safety risks of their sickle cell disease gene therapy after approval. If the...
Hospital seeks approval for embryonic stem cell treatment
By Japan Times A Japanese medical institution, in a first for the country, will seek government approval for using embryonic stem cells as a regenerative medicine product to treat babies with a severe liver ailment, sources close to the matter said Monday. The step...
Converting brain immune cells into neurons helps mice recover after stroke
By Kyushu University Fukuoka, Japan – Researchers at Kyushu University have discovered that turning brain immune cells into neurons successfully restores brain function after stroke-like injury in mice. These findings, published on October 10 in PNAS, suggest that...
Dublin Longevity Declaration Off to a Good Start
by Arkadi Mazin - Lifespan.io The need for a paradigm shift Last August, hundreds of longevity enthusiasts, from certified geroscience stars to graduate students, gathered in Dublin for the annual Longevity Summit conference. As the attendants were enjoying the...
Three people were gene-edited in an effort to cure their HIV. The result is unknown.
By Antonio Regalado - MIT Technology Review The gene-editing technology CRISPR has been used to change the genes of human babies, to modify animals, and to treat people with sickle-cell disease. Now scientists are attempting a new trick: using CRISPR to permanently...
Douglas Melton Recognized for Pioneering the Process of Converting Stem Cells into Insulin-Producing Beta Cells
By UMass Chan Medical School The UMass Chan Diabetes Center of Excellence (DCOE) congratulates Doug Melton, PhD, who was awarded the Doctor Juan Abarca International Award for Medical Sciences for pioneering the process of converting stem cells into insulin-producing...
Researchers Develop Novel Genome Editing Software That Is Safer Than CRISPR
by Technology Networks A team of researchers has developed a software tool called DANGER (Deleterious and ANticipatable Guides Evaluated by RNA-sequencing) analysis that provides a way for the safer design of genome editing in all organisms with a transcriptome. For...